FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to ophthalmology, and represents an ophthalmic film. Film contains 0.12 g of 6-methyl-3-(thietan-3-yl)uracil as a biologically active substance, and as a film-forming base - 3.3 g of polyvinyl alcohol per 100.0 ml of water.
EFFECT: use of the invention provides higher corneal tissue regeneration.
1 cl, 2 tbl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC DRUG FILM WITH METHYLURACIL EXHIBITING WOUND HEALING EFFECT | 2020 |
|
RU2740924C1 |
EYE OINTMENT BASED ON 6-METHYL-3-(THIETAN-3-YL)URACIL WITH WOUND-HEALING EFFECT | 2019 |
|
RU2705392C1 |
METHOD OF CONSERVATIVE TREATMENT OF ADAPTED PENETRATING WOUNDS OF THE CORNEA | 2016 |
|
RU2644701C1 |
METHOD FOR TREATMENT OF BURN OF EYES | 0 |
|
SU1827225A1 |
APPLICATION OF NOVEL OLIGOPEPTIDE FRAGMENTS OF PROTEIN S100b AS STIMULATORS AND MODULATORS OF REGENERATIVE PROCESSES IN EYE CORNEA | 2011 |
|
RU2496454C2 |
METHOD OF TREATING CORNEAL BURNS | 2021 |
|
RU2766298C2 |
EYE FILM | 1997 |
|
RU2173178C2 |
MEDICINE FOR TREATMENT OF KERATICONUS AND OTHER DEGENERATIVE DISEASES OF CORNEA AND PHARMACEUTICAL AGENTS BASED THEREON | 2013 |
|
RU2683651C2 |
OPHTHALMIC FILM | 2005 |
|
RU2286170C1 |
EYE MEDICINAL FILM | 2009 |
|
RU2404779C1 |
Authors
Dates
2021-01-21—Published
2020-06-09—Filed